Technology

Hologic Imager System

TML’s Cytopathology Department utilizes the Hologic ThinPrep┬« Imaging System to assist in primary cervical cancer screening of ThinPrep Pap Test slides.

This system uses computer imaging technology to evaluate for the presence of atypical cells, and cervical neoplasia, including its precursor lesions (low grade squamous intraepithelial lesion, high grade squamous intraepithelial lesion), and cervical carcinoma.

Our gynecologic cytology screening process combines revolutionary computer-assisted screening technology with human interpretive expertise to provide increased screening productivity and improved diagnostic accuracy.

Hologic Panther System

In September of 2012, TML acquired the Hologic Panther System with all samples pre-aliquoted by the Hologic Tomcat. The Panther is a fully-automated, random access sampling instrument which is FDA approved to perform Aptima CT/NG testing, Chlamydia trachomatis and Neisseria gonorrhea Nucleic Acid Amplification Test (NAATS).

A single one milliliter aliquot from a patient’s Thin Prep Pap Test vial can be tested for up to six different assays simultaneously on the Panther. FDA approval is currently pending for the Aptima HPV test.

HPV tests and CT/GC can be performed post pap processing. All thin prep vials are retained for a minimum of 30 days and molecular tests may be requested within 30 days of the collection of the Thin Prep Pap test.

Trichomonas vaginalis must be requested prior to pap processing; no post processing requests can be accepted. STD testing cannot be performed on patients under the age of 14. A genotyping assay for HPV 16,18,45 and HSV-1 and HSV-2 assays are currently in development.